BRINZOLAMIDE

BRINZOLAMIDE was reported 8693 times

BRINZOLAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMAUROSIS FUGAX 231 0.2145
1 URETERIC INJURY 10 0.0893
2 CONJUNCTIVAL SCAR 9 0.0596
3 NORMAL TENSION GLAUCOMA 6 0.0517
4 INTRAOCULAR PRESSURE FLUCTUATION 10 0.0508
5 PYROGLUTAMATE INCREASED 8 0.0497
6 INTRAOCULAR PRESSURE DECREASED 24 0.0455
7 URINARY TRACT DISORDER 200 0.0444
8 OPTIC NERVE CUPPING 5 0.0394
9 CORNEAL EXFOLIATION 4 0.0392
10 FLAT ANTERIOR CHAMBER OF EYE 7 0.0391
11 PYELITIS 8 0.0385
12 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 8 0.0351
13 INTRAOCULAR PRESSURE TEST ABNORMAL 24 0.0340
14 EPIDERMAL NECROSIS 32 0.0329
15 HAEMORRHAGIC STROKE 255 0.0326
16 CORNEAL INFECTION 7 0.0323
17 OCULAR PEMPHIGOID 4 0.0320
18 PUNCTATE KERATITIS 29 0.0316
19 IRIS HYPERPIGMENTATION 6 0.0288
20 SHORT STATURE 7 0.0267
21 DENTAL RESTORATION FAILURE 19 0.0264
22 INTRAOCULAR PRESSURE INCREASED 336 0.0263
23 EYE PARAESTHESIA 4 0.0255
24 OCULAR DISCOMFORT 285 0.0254
25 FLOPPY IRIS SYNDROME 9 0.0244
26 HEART FAILURE WITH PRESERVED EJECTION FRACTION 7 0.0238
27 PRODUCT DROPPER ISSUE 18 0.0229
28 GROWTH OF EYELASHES 18 0.0227
29 CORNEAL EROSION 12 0.0223
30 CHOROIDAL DETACHMENT 12 0.0216
31 CORNEAL OPACITY 29 0.0212
32 GLAUCOMA SURGERY 5 0.0195
33 VISUAL ACUITY REDUCED TRANSIENTLY 6 0.0195
34 KERATOMILEUSIS 5 0.0195
35 LENS DISLOCATION 4 0.0190
36 CORNEAL OEDEMA 40 0.0178
37 GENERALISED OEDEMA 218 0.0176
38 OPTIC DISC HAEMORRHAGE 4 0.0175
39 TREATMENT FAILURE 1429 0.0172
40 CORNEAL EPITHELIUM DEFECT 10 0.0172
41 CLOSTRIDIAL SEPSIS 4 0.0165
42 OPEN ANGLE GLAUCOMA 10 0.0163
43 IRIS ADHESIONS 8 0.0156
44 HYPHAEMA 8 0.0153
45 GLAUCOMA 282 0.0146
46 NASAL DISCHARGE DISCOLOURATION 20 0.0145
47 PANCREATIC NECROSIS 5 0.0144
48 OCULAR SURFACE DISEASE 4 0.0142
49 CORNEAL DISORDER 31 0.0141
50 OPTIC NERVE INJURY 16 0.0138
51 CONJUNCTIVAL HYPERAEMIA 49 0.0137
52 HEAD DISCOMFORT 239 0.0135
53 EYE ALLERGY 19 0.0123
54 ENDOCARDITIS STAPHYLOCOCCAL 6 0.0122
55 URETERAL DISORDER 5 0.0122
56 HYPOTONY OF EYE 5 0.0119
57 OCULAR HYPERTENSION 22 0.0113
58 PHOTOPHOBIA 204 0.0108
59 KERATIC PRECIPITATES 5 0.0105
60 ALTERED STATE OF CONSCIOUSNESS 228 0.0105
61 MACULAR FIBROSIS 7 0.0103
62 XEROPHTHALMIA 6 0.0102
63 FOREIGN BODY SENSATION IN EYES 65 0.0102
64 HAEMATEMESIS 252 0.0099
65 BLEPHARAL PIGMENTATION 5 0.0099
66 CORNEAL DEPOSITS 7 0.0094
67 BLINDNESS 378 0.0093
68 LENTICULAR OPACITIES 4 0.0092
69 ULCERATIVE KERATITIS 24 0.0088
70 EYE PAIN 491 0.0087
71 PRESYNCOPE 209 0.0086
72 LACRIMATION DECREASED 4 0.0084
73 DIPLOPIA 213 0.0082
74 OPTIC NERVE DISORDER 13 0.0081
75 EYELID MARGIN CRUSTING 23 0.0080
76 EYE COLOUR CHANGE 8 0.0079
77 PRODUCT DEPOSIT 12 0.0077
78 ASCITES 226 0.0077
79 ORAL MUCOSAL DISCOLOURATION 5 0.0075
80 CATARACT NUCLEAR 5 0.0075
81 CHOROIDAL EFFUSION 6 0.0075
82 CONJUNCTIVITIS ALLERGIC 11 0.0074
83 REACTION TO PRESERVATIVES 6 0.0074
84 EYELID DISORDER 17 0.0074
85 SCLERAL HYPERAEMIA 5 0.0073
86 ALTERED VISUAL DEPTH PERCEPTION 6 0.0073
87 CATHETER SITE PAIN 19 0.0073
88 BLOOD MAGNESIUM ABNORMAL 4 0.0072
89 VITREOUS OPACITIES 6 0.0071
90 EYE ULCER 4 0.0069
91 CYSTOID MACULAR OEDEMA 13 0.0069
92 PLEUROTHOTONUS 6 0.0066
93 RETINAL INJURY 5 0.0065
94 PRODUCT CONTAINER SEAL ISSUE 11 0.0063
95 VISUAL FIELD DEFECT 45 0.0062
96 CHONDROCALCINOSIS 4 0.0061
97 HAEMATURIA 207 0.0060
98 IRIDOCYCLITIS 19 0.0060
99 MACULAR HOLE 8 0.0060
100 WOUND HAEMORRHAGE 22 0.0059
101 KERATITIS 18 0.0059
102 MACULAR OEDEMA 33 0.0059
103 ANGLE CLOSURE GLAUCOMA 15 0.0059
104 CONGENITAL HYDRONEPHROSIS 4 0.0056
105 PRODUCT CONTAINER ISSUE 48 0.0056
106 CARDIO-RESPIRATORY ARREST 233 0.0056
107 OPTIC ATROPHY 9 0.0055
108 EYE IRRITATION 318 0.0055
109 SUPERFICIAL INJURY OF EYE 6 0.0055
110 COMA 254 0.0053
111 OPTIC NEUROPATHY 11 0.0052
112 EYE DISCHARGE 54 0.0052
113 TOXIC EPIDERMAL NECROLYSIS 78 0.0051
114 EPIGASTRIC DISCOMFORT 20 0.0051
115 BRONCHIAL CARCINOMA 4 0.0051
116 TINNITUS 232 0.0050
117 SMALL INTESTINAL HAEMORRHAGE 10 0.0050
118 ABNORMAL SENSATION IN EYE 21 0.0049
119 CONJUNCTIVAL OEDEMA 5 0.0049
120 OCULAR HYPERAEMIA 227 0.0048
121 BLINDNESS UNILATERAL 67 0.0047
122 HAEMORRHAGE URINARY TRACT 12 0.0047
123 RETINAL OEDEMA 9 0.0047
124 AGE-RELATED MACULAR DEGENERATION 7 0.0046
125 HERPES OPHTHALMIC 6 0.0045
126 VISUAL ACUITY REDUCED 148 0.0045
127 CORNEAL ABRASION 6 0.0044
128 BRONCHIAL OBSTRUCTION 6 0.0043
129 HYPERAESTHESIA 35 0.0043
130 ERYTHEMA OF EYELID 23 0.0042
131 RETINAL VASCULITIS 5 0.0042
132 ENCEPHALITIS 29 0.0042
133 PYELOCALIECTASIS 4 0.0042
134 FOREIGN BODY IN EYE 4 0.0042
135 RETINAL VEIN OCCLUSION 12 0.0042
136 PRODUCT MONITORING ERROR 6 0.0042
137 PHLEBITIS 21 0.0041
138 ACQUIRED HAEMOPHILIA 4 0.0040
139 EYELID IRRITATION 10 0.0040
140 EYELID PAIN 8 0.0039
141 RETINAL TOXICITY 4 0.0039
142 DACRYOSTENOSIS ACQUIRED 5 0.0039
143 RETINAL DEGENERATION 5 0.0038
144 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
145 BLEPHARITIS 15 0.0037
146 CATARACT 220 0.0037
147 EFFUSION 5 0.0037
148 EYE INJURY 11 0.0036
149 RETINAL ARTERY OCCLUSION 9 0.0036
150 DUODENAL ULCER HAEMORRHAGE 10 0.0035
151 PUPIL FIXED 6 0.0035
152 RETINAL DISORDER 9 0.0035
153 LIQUID PRODUCT PHYSICAL ISSUE 25 0.0034
154 MEDICATION RESIDUE PRESENT 16 0.0033
155 VENOUS OCCLUSION 6 0.0033
156 IRITIS 10 0.0033
157 VITREOUS HAEMORRHAGE 9 0.0033
158 METAMORPHOPSIA 6 0.0033
159 EYE OPERATION 15 0.0033
160 VITREOUS DETACHMENT 7 0.0032
161 INSTILLATION SITE PAIN 8 0.0032
162 EYE PRURITUS 106 0.0032
163 BLOOD PRESSURE DIASTOLIC ABNORMAL 8 0.0031
164 CONJUNCTIVAL HAEMORRHAGE 12 0.0031
165 VISION BLURRED 427 0.0031
166 EYE INFLAMMATION 29 0.0030
167 TACHYCARDIA 270 0.0030
168 ENDOPHTHALMITIS 18 0.0030
169 DEVICE DEPOSIT ISSUE 6 0.0029
170 MYOPIA 7 0.0029
171 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 4 0.0029
172 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
173 UVEITIS 38 0.0028
174 PRODUCT SUPPLY ISSUE 20 0.0028
175 SYNCOPE 280 0.0028
176 PLATELET DISORDER 7 0.0028
177 LACRIMATION INCREASED 82 0.0027
178 EYE INFECTION 30 0.0027
179 RETINAL DETACHMENT 24 0.0026
180 PYELONEPHRITIS ACUTE 5 0.0025
181 EYELID OEDEMA 29 0.0025
182 IMMUNE THROMBOCYTOPENIC PURPURA 7 0.0025
183 NEUTROPHIL COUNT ABNORMAL 7 0.0025
184 EYE OEDEMA 6 0.0024
185 DERMAL CYST 6 0.0024
186 BLINDNESS TRANSIENT 18 0.0024
187 CONCOMITANT DISEASE AGGRAVATED 15 0.0024
188 RASH PAPULAR 54 0.0024
189 MALIGNANT PLEURAL EFFUSION 4 0.0024
190 CEREBELLAR INFARCTION 4 0.0024
191 ASTHENOPIA 13 0.0024
192 CHILLS 275 0.0023
193 MACULAR DEGENERATION 28 0.0023
194 MACULOPATHY 8 0.0023
195 EYE HAEMORRHAGE 30 0.0022
196 EYELIDS PRURITUS 7 0.0022
197 DRY EYE 112 0.0022
198 POOR VENOUS ACCESS 23 0.0022
199 EYE DISORDER 73 0.0022
200 HYPOTONIA 22 0.0022
201 LIP BLISTER 6 0.0022
202 PANCREATITIS NECROTISING 5 0.0022
203 NEPHROGENIC ANAEMIA 10 0.0022
204 SEPSIS 240 0.0021
205 STOMA SITE ERYTHEMA 4 0.0021
206 BRADYCARDIA 112 0.0021
207 CEREBRAL HAEMATOMA 7 0.0021
208 APHTHOUS ULCER 16 0.0021
209 DIABETIC RETINOPATHY 7 0.0021
210 APNOEA 16 0.0021
211 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
212 EYE SWELLING 76 0.0020
213 STRABISMUS 6 0.0020
214 PRODUCT RESIDUE PRESENT 11 0.0020
215 BLOOD CULTURE POSITIVE 6 0.0020
216 HYPERPARATHYROIDISM SECONDARY 5 0.0020
217 PRODUCT PHYSICAL CONSISTENCY ISSUE 11 0.0020
218 RETINAL HAEMORRHAGE 14 0.0020
219 DYSCHEZIA 6 0.0020
220 INCREASED BRONCHIAL SECRETION 5 0.0020
221 ULCER 31 0.0019
222 BLOOD PRESSURE INCREASED 293 0.0019
223 PHARYNGEAL ERYTHEMA 4 0.0019
224 WEIGHT BEARING DIFFICULTY 5 0.0019
225 PERIODONTITIS 4 0.0018
226 EAR CONGESTION 5 0.0018
227 ELECTROLYTE IMBALANCE 21 0.0018
228 FLUID INTAKE REDUCED 9 0.0018
229 ADENOCARCINOMA 4 0.0018
230 VISUAL IMPAIRMENT 220 0.0018
231 PHOTOPSIA 11 0.0017
232 VITREOUS FLOATERS 17 0.0017
233 SCREAMING 11 0.0017
234 THERAPEUTIC REACTION TIME DECREASED 5 0.0017
235 CREPITATIONS 5 0.0017
236 BLOOD IMMUNOGLOBULIN E INCREASED 4 0.0017
237 MENINGITIS 11 0.0016
238 CAROTID ARTERY OCCLUSION 6 0.0016
239 CARDIAC FAILURE CHRONIC 7 0.0016
240 BREATH ODOUR 4 0.0016
241 RETINAL TEAR 4 0.0016
242 SUFFOCATION FEELING 4 0.0016
243 RETINOPATHY 6 0.0016
244 MIDDLE INSOMNIA 30 0.0016
245 HYPERNATRAEMIA 8 0.0016
246 MYALGIA 272 0.0016
247 SWELLING OF EYELID 10 0.0016
248 LABYRINTHITIS 4 0.0016
249 PRODUCT PACKAGING ISSUE 15 0.0016
250 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
251 PANCREATITIS ACUTE 35 0.0016
252 HEART RATE DECREASED 54 0.0015
253 SUBDURAL HAEMATOMA 22 0.0015
254 BLOOD COUNT ABNORMAL 23 0.0015
255 CATARACT OPERATION 9 0.0015
256 ARTERIOSCLEROSIS CORONARY ARTERY 10 0.0015
257 BLOOD MAGNESIUM DECREASED 13 0.0015
258 SOMNOLENCE 302 0.0015
259 MIOSIS 12 0.0015
260 IMMUNE-MEDIATED MYOSITIS 4 0.0014
261 APATHY 21 0.0014
262 NASAL DRYNESS 9 0.0014
263 HALLUCINATIONS, MIXED 6 0.0014
264 CONJUNCTIVITIS 26 0.0014
265 PERSONALITY CHANGE 13 0.0014
266 HAEMOGLOBIN DECREASED 143 0.0014
267 HORDEOLUM 6 0.0014
268 FALL 454 0.0014
269 MUSCLE RIGIDITY 16 0.0013
270 METABOLIC ENCEPHALOPATHY 4 0.0013
271 HYPERCAPNIA 4 0.0013
272 REBOUND ACID HYPERSECRETION 4 0.0013
273 ABNORMAL LOSS OF WEIGHT 9 0.0013
274 INGUINAL HERNIA 8 0.0013
275 EAR DISORDER 6 0.0013
276 HYPERSENSITIVITY 243 0.0013
277 PRODUCT DELIVERY MECHANISM ISSUE 7 0.0013
278 TENDON RUPTURE 16 0.0013
279 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 22 0.0013
280 COVID-19 PNEUMONIA 15 0.0013
281 EOSINOPHILIC PNEUMONIA 4 0.0013
282 SUSPECTED COUNTERFEIT PRODUCT 5 0.0013
283 BRONCHOSPASM 18 0.0013
284 PRODUCT LEAKAGE 7 0.0012
285 ABDOMINAL PAIN 288 0.0012
286 PERIORBITAL SWELLING 7 0.0012
287 HYPOPHAGIA 31 0.0012
288 ORGANISING PNEUMONIA 6 0.0012
289 ABDOMINAL PAIN UPPER 249 0.0012
290 ORTHOSTATIC HYPOTENSION 21 0.0012
291 KETOACIDOSIS 9 0.0012
292 HYDRONEPHROSIS 9 0.0012
293 PEMPHIGOID 9 0.0012
294 PRODUCT ADMINISTRATION ERROR 24 0.0012
295 EYELID PTOSIS 12 0.0012
296 LIP OEDEMA 5 0.0012
297 PRODUCT LABEL ISSUE 8 0.0012
298 HEPATIC CYST 4 0.0012
299 COUGH 330 0.0012
300 BOWEL MOVEMENT IRREGULARITY 9 0.0012
301 HYPONATRAEMIA 66 0.0012
302 RASH ERYTHEMATOUS 56 0.0012
303 MICTURITION DISORDER 4 0.0012
304 HYPOPNOEA 4 0.0012
305 TOOTH INJURY 5 0.0012
306 HAEMORRHAGIC ANAEMIA 5 0.0011
307 MELAENA 25 0.0011
308 DECREASED APPETITE 261 0.0011
309 HAEMORRHAGIC DIATHESIS 4 0.0011
310 HYPOACUSIS 48 0.0011
311 DRUG INTERACTION 176 0.0011
312 ASTHENIA 416 0.0011
313 SCLERODERMA 4 0.0011
314 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
315 LOCALISED OEDEMA 5 0.0011
316 FREEZING PHENOMENON 4 0.0011
317 FUNGAL INFECTION 36 0.0011
318 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
319 HAEMORRHAGE INTRACRANIAL 16 0.0011
320 INSOMNIA 284 0.0011
321 CHRONIC SINUSITIS 4 0.0011
322 SOPOR 14 0.0011
323 ARRHYTHMIA 50 0.0011
324 CARDIAC FAILURE ACUTE 7 0.0010
325 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
326 DYSPNOEA 590 0.0010
327 HAEMATOMA 27 0.0010
328 GINGIVAL DISORDER 4 0.0010
329 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
330 OESOPHAGEAL PAIN 4 0.0010
331 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
332 EXPIRED DRUG ADMINISTERED 5 0.0010
333 DIZZINESS 503 0.0010
334 DEAFNESS 26 0.0010
335 RHINITIS 8 0.0010
336 HYPOTHERMIA 10 0.0010
337 INCREASED UPPER AIRWAY SECRETION 5 0.0010
338 HYPERURICAEMIA 4 0.0010
339 SPINAL COMPRESSION FRACTURE 8 0.0010
340 PERIORBITAL OEDEMA 5 0.0010
341 THROAT IRRITATION 43 0.0010
342 FIBROMYALGIA 23 0.0009
343 AORTIC VALVE INCOMPETENCE 4 0.0009
344 ABSCESS LIMB 4 0.0009
345 BODY HEIGHT DECREASED 10 0.0009
346 CARDIAC FLUTTER 6 0.0009
347 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
348 TENDON DISORDER 6 0.0009
349 DRY MOUTH 74 0.0009
350 PARONYCHIA 4 0.0009
351 DEAFNESS UNILATERAL 5 0.0009
352 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
353 MALAISE 396 0.0009
354 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
355 HALLUCINATION, VISUAL 19 0.0009
356 ARTHRALGIA 373 0.0009
357 JAUNDICE 24 0.0009
358 HEART RATE IRREGULAR 20 0.0009
359 RHINORRHOEA 57 0.0009
360 MEDICATION ERROR 49 0.0009
361 PNEUMONIA ASPIRATION 22 0.0009
362 CARDIOMYOPATHY 13 0.0009
363 PERIPHERAL COLDNESS 12 0.0009
364 SKIN ATROPHY 5 0.0009
365 MUSCLE ATROPHY 11 0.0009
366 LYMPHOEDEMA 6 0.0009
367 HYPOKALAEMIA 40 0.0009
368 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
369 MADAROSIS 10 0.0009
370 EXTRASYSTOLES 6 0.0009
371 ASTHMA 97 0.0009
372 HEAD INJURY 27 0.0009
373 FULL BLOOD COUNT ABNORMAL 9 0.0009
374 SQUAMOUS CELL CARCINOMA 8 0.0008
375 DIVERTICULUM 6 0.0008
376 ATRIAL FIBRILLATION 82 0.0008
377 CARDIOGENIC SHOCK 12 0.0008
378 PRURITUS 321 0.0008
379 PRODUCT USE COMPLAINT 13 0.0008
380 TENSION 5 0.0008
381 MOUTH HAEMORRHAGE 6 0.0008
382 PYREXIA 282 0.0008
383 SKIN HYPERPIGMENTATION 7 0.0008
384 SINUS CONGESTION 11 0.0008
385 HYPERCALCAEMIA 10 0.0008
386 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
387 CHOLANGITIS 5 0.0008
388 MALNUTRITION 9 0.0008
389 ORAL PAIN 18 0.0008
390 NAIL DISORDER 7 0.0008
391 PAROSMIA 6 0.0008
392 PRODUCT AVAILABILITY ISSUE 18 0.0008
393 DYSLIPIDAEMIA 4 0.0008
394 LIPASE INCREASED 6 0.0008
395 FEMORAL NECK FRACTURE 4 0.0008
396 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
397 HIATUS HERNIA 10 0.0008
398 EAR PAIN 15 0.0008
399 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 37 0.0008
400 CIRCULATORY COLLAPSE 13 0.0008
401 EPISTAXIS 57 0.0008
402 ACCIDENT 9 0.0008
403 DYSPHONIA 44 0.0008
404 PANIC ATTACK 27 0.0007
405 UNRESPONSIVE TO STIMULI 19 0.0007
406 PALLOR 20 0.0007
407 ASPHYXIA 6 0.0007
408 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
409 INFARCTION 5 0.0007
410 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
411 DIARRHOEA 469 0.0007
412 WHEEZING 43 0.0007
413 HYPERCHOLESTEROLAEMIA 7 0.0007
414 EXTRAPYRAMIDAL DISORDER 18 0.0007
415 ATELECTASIS 7 0.0007
416 EXPIRED PRODUCT ADMINISTERED 24 0.0007
417 BLOOD UREA INCREASED 12 0.0007
418 THYROID DISORDER 11 0.0007
419 HEADACHE 446 0.0007
420 UPPER LIMB FRACTURE 14 0.0007
421 CONFUSIONAL STATE 113 0.0007
422 ACUTE KIDNEY INJURY 106 0.0007
423 BLOOD PRESSURE DECREASED 46 0.0007
424 DYSPEPSIA 68 0.0007
425 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
426 MENTAL STATUS CHANGES 19 0.0007
427 AGEUSIA 17 0.0007
428 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
429 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
430 ACUTE RESPIRATORY FAILURE 13 0.0007
431 BACTERAEMIA 8 0.0007
432 DYSGEUSIA 50 0.0007
433 CARDIAC PACEMAKER INSERTION 4 0.0007
434 TRANSFUSION 7 0.0007
435 HEARING IMPAIRED 4 0.0007
436 BLOOD PRESSURE FLUCTUATION 16 0.0007
437 RENAL IMPAIRMENT 56 0.0007
438 GENERAL PHYSICAL HEALTH DETERIORATION 77 0.0007
439 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
440 ANGINA PECTORIS 19 0.0007
441 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
442 ERECTILE DYSFUNCTION 17 0.0007
443 RENAL FAILURE ACUTE 28 0.0007
444 VOMITING 310 0.0007
445 END STAGE RENAL DISEASE 12 0.0007
446 CARDIOMEGALY 8 0.0006
447 POOR QUALITY SLEEP 14 0.0006
448 IRON DEFICIENCY ANAEMIA 6 0.0006
449 SKIN LACERATION 7 0.0006
450 LUNG INFECTION 10 0.0006
451 BACTERIAL INFECTION 12 0.0006
452 PELVIC FRACTURE 5 0.0006
453 OESOPHAGITIS 7 0.0006
454 HYPOGLYCAEMIA 31 0.0006
455 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
456 DERMATITIS ALLERGIC 8 0.0006
457 FEAR 17 0.0006
458 LIVER DISORDER 28 0.0006
459 PRODUCTIVE COUGH 30 0.0006
460 THERAPEUTIC PRODUCT EFFECT DECREASED 28 0.0006
461 UTERINE CANCER 5 0.0006
462 HIP FRACTURE 20 0.0006
463 HYPOKINESIA 9 0.0006
464 CHRONIC KIDNEY DISEASE 47 0.0006
465 MOUTH ULCERATION 13 0.0006
466 SCAB 7 0.0006
467 PHARYNGEAL SWELLING 6 0.0006
468 FATIGUE 476 0.0006
469 BODY TEMPERATURE DECREASED 6 0.0006
470 SKIN DISCOLOURATION 28 0.0006
471 JOINT INJURY 13 0.0006
472 DEMENTIA 17 0.0006
473 WOUND 17 0.0006
474 ESCHERICHIA INFECTION 5 0.0006
475 DYSGRAPHIA 4 0.0006
476 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
477 HAEMATOCRIT DECREASED 12 0.0006
478 ACUTE CORONARY SYNDROME 5 0.0006
479 LIP SWELLING 20 0.0006
480 SALIVARY HYPERSECRETION 6 0.0006
481 SKIN MASS 4 0.0006
482 SWELLING 56 0.0006
483 EMPHYSEMA 6 0.0006
484 BRONCHIECTASIS 4 0.0006
485 LETHARGY 34 0.0006
486 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 42 0.0006
487 HYPERTENSION 125 0.0006
488 EPILEPSY 18 0.0006
489 FACIAL PARALYSIS 5 0.0006
490 PHARYNGEAL OEDEMA 9 0.0006
491 EAR DISCOMFORT 6 0.0006
492 FRACTURE 11 0.0006
493 MUSCULAR WEAKNESS 66 0.0006
494 FOOT FRACTURE 11 0.0006
495 SNEEZING 13 0.0006
496 HAIR GROWTH ABNORMAL 4 0.0006
497 CARDIAC MURMUR 5 0.0006
498 LARGE INTESTINE POLYP 4 0.0006
499 HYPERTRANSAMINASAEMIA 4 0.0006
500 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 30 0.0006
501 DISTURBANCE IN ATTENTION 31 0.0006
502 FEELING COLD 16 0.0006
503 HYPOMAGNESAEMIA 8 0.0006
504 PALPITATIONS 67 0.0006
505 JOINT SWELLING 69 0.0006
506 HYPERKALAEMIA 20 0.0006
507 BLOOD CALCIUM INCREASED 5 0.0006
508 GRIP STRENGTH DECREASED 5 0.0006
509 PNEUMOTHORAX 9 0.0006
510 RENAL PAIN 6 0.0006
511 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
512 SEASONAL ALLERGY 8 0.0006
513 RED BLOOD CELL COUNT DECREASED 16 0.0006
514 CEREBRAL HAEMORRHAGE 20 0.0006
515 ANAL INCONTINENCE 5 0.0006
516 BALANCE DISORDER 48 0.0006
517 PRURITUS GENERALISED 12 0.0006
518 SWELLING FACE 36 0.0006
519 BLOOD CREATININE INCREASED 36 0.0006
520 OPTIC NEURITIS 5 0.0005
521 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
522 ARTHRITIS 43 0.0005
523 PRODUCT PRESCRIBING ERROR 13 0.0005
524 PHOTOSENSITIVITY REACTION 9 0.0005
525 PRODUCT QUALITY ISSUE 74 0.0005
526 UROSEPSIS 5 0.0005
527 PSYCHIATRIC SYMPTOM 4 0.0005
528 COAGULOPATHY 9 0.0005
529 DIABETES MELLITUS 41 0.0005
530 ERYTHEMA MULTIFORME 5 0.0005
531 CANDIDA INFECTION 9 0.0005
532 CEREBRAL INFARCTION 13 0.0005
533 HEMIPARESIS 9 0.0005
534 PULMONARY CONGESTION 7 0.0005
535 BLOOD SODIUM DECREASED 10 0.0005
536 SEPTIC SHOCK 23 0.0005
537 BRONCHITIS 39 0.0005
538 DERMATITIS CONTACT 6 0.0005
539 MICTURITION URGENCY 6 0.0005
540 HYPERTHERMIA 4 0.0005
541 MYOCARDITIS 6 0.0005
542 THROMBOSIS 42 0.0005
543 PULMONARY FIBROSIS 10 0.0005
544 AFFECT LABILITY 5 0.0005
545 HOT FLUSH 39 0.0005
546 ATRIOVENTRICULAR BLOCK 4 0.0005
547 GASTROINTESTINAL HAEMORRHAGE 43 0.0005
548 VITAMIN D DEFICIENCY 5 0.0005
549 SWOLLEN TONGUE 16 0.0005
550 CORONARY ARTERY OCCLUSION 7 0.0005
551 HOSPICE CARE 5 0.0005
552 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
553 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
554 RESPIRATORY TRACT CONGESTION 8 0.0005
555 GINGIVAL PAIN 4 0.0005
556 GOUT 9 0.0005
557 RESPIRATORY DISORDER 15 0.0005
558 MASS 7 0.0005
559 METABOLIC ACIDOSIS 16 0.0005
560 SINUSITIS 51 0.0005
561 NOCTURIA 6 0.0005
562 NAUSEA 391 0.0005
563 HYPERGLYCAEMIA 18 0.0005
564 TASTE DISORDER 10 0.0005
565 BONE MARROW FAILURE 10 0.0005
566 DRY THROAT 5 0.0005
567 SUBARACHNOID HAEMORRHAGE 5 0.0005
568 PARALYSIS 7 0.0005
569 LIVER INJURY 12 0.0005
570 POLYURIA 4 0.0005
571 FEMUR FRACTURE 15 0.0005
572 PHARYNGITIS 6 0.0005
573 PANCYTOPENIA 27 0.0005
574 HYPOXIA 17 0.0005
575 GAIT DISTURBANCE 92 0.0005
576 EOSINOPHIL COUNT INCREASED 4 0.0005
577 TENDERNESS 5 0.0005
578 MUSCULOSKELETAL STIFFNESS 42 0.0005
579 PRODUCT ODOUR ABNORMAL 5 0.0005
580 VERTIGO 29 0.0005
581 OROPHARYNGEAL PAIN 44 0.0005
582 SCRATCH 5 0.0005
583 GASTRIC ULCER 9 0.0005
584 CARDIAC FAILURE 38 0.0005
585 BLOOD CHOLESTEROL INCREASED 22 0.0005
586 HEPATIC CYTOLYSIS 6 0.0005
587 CARDIAC DISORDER 44 0.0005
588 LUNG DISORDER 23 0.0005
589 MYDRIASIS 6 0.0005
590 OEDEMA PERIPHERAL 57 0.0005
591 C-REACTIVE PROTEIN INCREASED 17 0.0005
592 CORONARY ARTERY DISEASE 14 0.0005
593 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
594 NASOPHARYNGITIS 85 0.0005
595 RESPIRATORY TRACT INFECTION 12 0.0005
596 NERVOUSNESS 24 0.0005
597 DRUG DISPENSING ERROR 7 0.0005
598 DRUG ADMINISTRATION ERROR 14 0.0005
599 ORAL CANDIDIASIS 6 0.0005
600 POLLAKIURIA 19 0.0005
601 DRUG INTOLERANCE 44 0.0005
602 DYSPHAGIA 43 0.0005
603 LYMPHOMA 7 0.0005
604 MUSCULOSKELETAL CHEST PAIN 7 0.0005
605 TENDONITIS 7 0.0005
606 HALLUCINATION 34 0.0005
607 FOOT DEFORMITY 5 0.0005
608 RENAL DISORDER 21 0.0005
609 RESPIRATORY RATE INCREASED 4 0.0005
610 URINARY RETENTION 15 0.0004
611 HAIR TEXTURE ABNORMAL 6 0.0004
612 FACIAL PAIN 4 0.0004
613 FULL BLOOD COUNT DECREASED 9 0.0004
614 FREQUENT BOWEL MOVEMENTS 12 0.0004
615 CONDITION AGGRAVATED 135 0.0004
616 PLEURAL EFFUSION 27 0.0004
617 OROPHARYNGEAL DISCOMFORT 4 0.0004
618 ANAEMIA 84 0.0004
619 TREMOR 72 0.0004
620 BLOOD POTASSIUM DECREASED 13 0.0004
621 MUSCLE TIGHTNESS 7 0.0004
622 HAEMOPTYSIS 12 0.0004
623 DIARRHOEA HAEMORRHAGIC 4 0.0004
624 DEHYDRATION 57 0.0004
625 OXYGEN SATURATION DECREASED 24 0.0004
626 SPINAL PAIN 5 0.0004
627 LACERATION 4 0.0004
628 DYSPNOEA EXERTIONAL 16 0.0004
629 RASH PRURITIC 23 0.0004
630 HYPOCALCAEMIA 8 0.0004
631 SPUTUM DISCOLOURED 4 0.0004
632 MUSCULOSKELETAL PAIN 22 0.0004
633 SPEECH DISORDER 22 0.0004
634 SLEEP APNOEA SYNDROME 8 0.0004
635 HYPERLIPIDAEMIA 5 0.0004
636 GASTRITIS 11 0.0004
637 POLYNEUROPATHY 5 0.0004
638 BACK PAIN 97 0.0004
639 WRIST FRACTURE 5 0.0004
640 CONTUSION 40 0.0004
641 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
642 HEART RATE INCREASED 41 0.0004
643 SINUS BRADYCARDIA 4 0.0004
644 BURNING SENSATION 29 0.0004
645 ADRENAL INSUFFICIENCY 5 0.0004
646 CHEST DISCOMFORT 42 0.0004
647 HAEMORRHOIDS 8 0.0004
648 CHOKING 8 0.0004
649 BLISTER 23 0.0004
650 NASAL CONGESTION 24 0.0004
651 CYTOPENIA 5 0.0004
652 DYSURIA 15 0.0004
653 INFUSION RELATED REACTION 27 0.0004
654 MUSCULOSKELETAL DISCOMFORT 7 0.0004
655 THROAT TIGHTNESS 11 0.0004
656 ABDOMINAL DISCOMFORT 68 0.0004
657 LIMB INJURY 11 0.0004
658 STEVENS-JOHNSON SYNDROME 9 0.0004
659 PAIN IN EXTREMITY 119 0.0004
660 NIGHT SWEATS 13 0.0004
661 HAIR COLOUR CHANGES 5 0.0004
662 THERAPY NON-RESPONDER 18 0.0004
663 CHEST PAIN 74 0.0004
664 PRODUCT SUBSTITUTION ISSUE 23 0.0004
665 METASTASES TO LIVER 7 0.0004
666 LOSS OF CONSCIOUSNESS 51 0.0004
667 HYPOAESTHESIA ORAL 6 0.0004
668 DIVERTICULITIS 11 0.0004
669 LOWER RESPIRATORY TRACT INFECTION 18 0.0004
670 OFF LABEL USE 346 0.0004
671 DYSKINESIA 16 0.0004
672 NECK PAIN 22 0.0004
673 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
674 BODY TEMPERATURE INCREASED 8 0.0004
675 ROTATOR CUFF SYNDROME 5 0.0004
676 DRUG INEFFECTIVE 512 0.0004
677 RASH GENERALISED 10 0.0004
678 PLATELET COUNT INCREASED 5 0.0004
679 CYANOSIS 6 0.0004
680 HAEMATOCHEZIA 21 0.0004
681 HYPOTENSION 76 0.0004
682 INCONTINENCE 4 0.0004
683 CEREBROVASCULAR ACCIDENT 64 0.0004
684 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
685 CYSTITIS 12 0.0004
686 AGRANULOCYTOSIS 7 0.0004
687 RENAL FAILURE 50 0.0004
688 BREAST PAIN 4 0.0004
689 RECTAL HAEMORRHAGE 16 0.0004
690 INTERSTITIAL LUNG DISEASE 18 0.0004
691 URINARY INCONTINENCE 11 0.0004
692 DECREASED ACTIVITY 4 0.0004
693 ERYTHEMA 76 0.0004
694 PRODUCT TASTE ABNORMAL 5 0.0004
695 FAECES DISCOLOURED 8 0.0004
696 PRODUCT PRESCRIBING ISSUE 8 0.0004
697 ASPIRATION 4 0.0004
698 APHASIA 11 0.0004
699 ABASIA 9 0.0004
700 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
701 CARDIAC FAILURE CONGESTIVE 29 0.0004
702 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
703 GASTROOESOPHAGEAL REFLUX DISEASE 29 0.0004
704 TRANSAMINASES INCREASED 8 0.0004
705 PULMONARY OEDEMA 16 0.0004
706 KIDNEY INFECTION 7 0.0004
707 ABDOMINAL PAIN LOWER 9 0.0004
708 DEVICE OCCLUSION 5 0.0004
709 BLOOD GLUCOSE DECREASED 17 0.0004
710 DISORIENTATION 14 0.0004
711 FLATULENCE 20 0.0004
712 IMPAIRED DRIVING ABILITY 4 0.0004
713 MYOCARDIAL ISCHAEMIA 4 0.0004
714 SCAR 6 0.0004
715 SPINAL FRACTURE 7 0.0003
716 ANAPHYLACTIC SHOCK 9 0.0003
717 NIGHTMARE 12 0.0003
718 PARAESTHESIA ORAL 5 0.0003
719 POST PROCEDURAL HAEMORRHAGE 4 0.0003
720 PNEUMONIA 111 0.0003
721 MOVEMENT DISORDER 11 0.0003
722 EOSINOPHILIA 6 0.0003
723 SEXUAL DYSFUNCTION 4 0.0003
724 COLD SWEAT 6 0.0003
725 RIB FRACTURE 7 0.0003
726 DRUG ERUPTION 6 0.0003
727 BREAST CANCER FEMALE 9 0.0003
728 PULMONARY EMBOLISM 32 0.0003
729 ISCHAEMIC STROKE 6 0.0003
730 OSTEOMYELITIS 6 0.0003
731 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
732 RESTLESS LEGS SYNDROME 6 0.0003
733 EATING DISORDER 7 0.0003
734 SKIN LESION 9 0.0003
735 ACCIDENTAL OVERDOSE 12 0.0003
736 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
737 ANGER 11 0.0003
738 LIMB DISCOMFORT 10 0.0003
739 ANKLE FRACTURE 5 0.0003
740 HYPOAESTHESIA 48 0.0003
741 GASTRIC DISORDER 11 0.0003
742 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
743 CELLULITIS 16 0.0003
744 BLOOD URINE PRESENT 6 0.0003
745 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
746 HEPATITIS 8 0.0003
747 DEPRESSION 71 0.0003
748 DISCOMFORT 19 0.0003
749 ACCIDENTAL EXPOSURE TO PRODUCT 32 0.0003
750 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
751 ERUCTATION 6 0.0003
752 CHROMATURIA 7 0.0003
753 LIVER FUNCTION TEST ABNORMAL 9 0.0003
754 DYSSTASIA 9 0.0003
755 ANAPHYLACTIC REACTION 17 0.0003
756 AMNESIA 20 0.0003
757 PAIN 188 0.0003
758 ECZEMA 16 0.0003
759 PERIPHERAL SWELLING 47 0.0003
760 CHOLELITHIASIS 10 0.0003
761 URINARY TRACT INFECTION 52 0.0003
762 INCORRECT PRODUCT STORAGE 4 0.0003
763 SHOCK 7 0.0003
764 MYOCARDIAL INFARCTION 53 0.0003
765 DISABILITY 6 0.0003
766 STAPHYLOCOCCAL INFECTION 10 0.0003
767 PERICARDIAL EFFUSION 7 0.0003
768 PRESCRIBED UNDERDOSE 6 0.0003
769 JOINT RANGE OF MOTION DECREASED 4 0.0003
770 SLEEP DISORDER 21 0.0003
771 FACE OEDEMA 5 0.0003
772 ALOPECIA 58 0.0003
773 OEDEMA 16 0.0003
774 CONSTIPATION 64 0.0003
775 MOOD ALTERED 8 0.0003
776 GINGIVAL BLEEDING 4 0.0003
777 NEURALGIA 7 0.0003
778 HYPERHIDROSIS 37 0.0003
779 COORDINATION ABNORMAL 4 0.0003
780 RASH MACULAR 10 0.0003
781 CARPAL TUNNEL SYNDROME 4 0.0003
782 ENCEPHALOPATHY 7 0.0003
783 NEPHROLITHIASIS 13 0.0003
784 LYMPHOCYTE COUNT DECREASED 5 0.0003
785 DIALYSIS 4 0.0003
786 HYPOTHYROIDISM 9 0.0003
787 SINUS TACHYCARDIA 4 0.0003
788 THERAPEUTIC RESPONSE DECREASED 17 0.0003
789 THIRST 5 0.0003
790 IRRITABLE BOWEL SYNDROME 6 0.0003
791 COGNITIVE DISORDER 13 0.0003
792 MOBILITY DECREASED 20 0.0003
793 GASTROENTERITIS VIRAL 5 0.0003
794 CRYING 10 0.0003
795 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
796 PARAESTHESIA 43 0.0003
797 BONE PAIN 16 0.0003
798 WEIGHT DECREASED 76 0.0003
799 INCORRECT DOSE ADMINISTERED 62 0.0003
800 INFLAMMATION 14 0.0003
801 ANGIOEDEMA 12 0.0003
802 SKIN ULCER 7 0.0003
803 ARTHROPATHY 15 0.0003
804 TOOTH DISORDER 6 0.0003
805 NEOPLASM MALIGNANT 18 0.0003
806 RENAL INJURY 8 0.0003
807 MEMORY IMPAIRMENT 37 0.0003
808 HEPATIC STEATOSIS 5 0.0003
809 GLOSSODYNIA 6 0.0003
810 LUNG NEOPLASM MALIGNANT 11 0.0003
811 FEELING ABNORMAL 64 0.0003
812 JOINT STIFFNESS 7 0.0003
813 STOMATITIS 16 0.0003
814 COLITIS 10 0.0003
815 ANXIETY 75 0.0003
816 MUSCULOSKELETAL DISORDER 5 0.0003
817 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
818 MUSCLE SPASMS 48 0.0003
819 FEELING HOT 16 0.0003
820 PRODUCT DOSE OMISSION 17 0.0003
821 LOWER LIMB FRACTURE 5 0.0003
822 DRUG PRESCRIBING ERROR 5 0.0003
823 LEUKOPENIA 13 0.0003
824 AGGRESSION 13 0.0003
825 NO ADVERSE EVENT 47 0.0003
826 BLOOD BILIRUBIN INCREASED 7 0.0003
827 PRESCRIBED OVERDOSE 5 0.0003
828 BASAL CELL CARCINOMA 4 0.0003
829 FEBRILE NEUTROPENIA 17 0.0003
830 ABNORMAL BEHAVIOUR 10 0.0003
831 BLOOD PRESSURE ABNORMAL 5 0.0003
832 SCIATICA 4 0.0003
833 ACNE 19 0.0003
834 SENSORY DISTURBANCE 4 0.0002
835 PAIN IN JAW 7 0.0002
836 DISEASE PROGRESSION 29 0.0002
837 PRODUCT USE ISSUE 46 0.0002
838 HERPES ZOSTER 14 0.0002
839 OSTEOPOROSIS 10 0.0002
840 OSTEONECROSIS OF JAW 6 0.0002
841 INTENTIONAL DRUG MISUSE 5 0.0002
842 DYSARTHRIA 9 0.0002
843 BLOOD GLUCOSE INCREASED 45 0.0002
844 DERMATITIS 5 0.0002
845 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
846 FLUID RETENTION 12 0.0002
847 AGITATION 17 0.0002
848 NEUROPATHY PERIPHERAL 22 0.0002
849 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
850 LOCAL SWELLING 4 0.0002
851 MUCOSAL INFLAMMATION 6 0.0002
852 SEDATION 6 0.0002
853 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
854 PRODUCT USE IN UNAPPROVED INDICATION 56 0.0002
855 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
856 RASH MACULO-PAPULAR 5 0.0002
857 GALLBLADDER DISORDER 4 0.0002
858 THROMBOCYTOPENIA 25 0.0002
859 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
860 RESTLESSNESS 8 0.0002
861 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
862 RASH 95 0.0002
863 MUSCLE TWITCHING 5 0.0002
864 BLOOD GLUCOSE ABNORMAL 4 0.0002
865 SEIZURE 25 0.0002
866 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
867 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 39 0.0002
868 DEEP VEIN THROMBOSIS 14 0.0002
869 HEPATIC FUNCTION ABNORMAL 8 0.0002
870 OSTEOARTHRITIS 9 0.0002
871 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
872 INTENTIONAL DOSE OMISSION 6 0.0002
873 PROTEINURIA 4 0.0002
874 SKIN DISORDER 7 0.0002
875 CHOLESTASIS 4 0.0002
876 PANCREATITIS 11 0.0002
877 TYPE 2 DIABETES MELLITUS 7 0.0002
878 INFLUENZA 23 0.0002
879 RESPIRATORY FAILURE 15 0.0002
880 ORAL HERPES 4 0.0002
881 HEPATIC FAILURE 6 0.0002
882 ILL-DEFINED DISORDER 12 0.0002
883 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
884 PRODUCT STORAGE ERROR 17 0.0002
885 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
886 PERITONITIS 4 0.0002
887 DRUG EFFECT INCOMPLETE 7 0.0002
888 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39 0.0002
889 PULMONARY HYPERTENSION 4 0.0002
890 HAEMORRHAGE 20 0.0002
891 TOXICITY TO VARIOUS AGENTS 32 0.0002
892 DEPRESSED MOOD 10 0.0002
893 INJURY 13 0.0002
894 ABDOMINAL DISTENSION 19 0.0002
895 CARDIAC ARREST 15 0.0002
896 RESPIRATORY ARREST 5 0.0002
897 RESPIRATORY DISTRESS 5 0.0002
898 PLATELET COUNT DECREASED 19 0.0002
899 HYPERSOMNIA 5 0.0002
900 URTICARIA 29 0.0002
901 INJECTION SITE PAIN 53 0.0002
902 NEOPLASM PROGRESSION 6 0.0002
903 ACUTE MYOCARDIAL INFARCTION 5 0.0002
904 LYMPHADENOPATHY 6 0.0002
905 GASTROINTESTINAL DISORDER 15 0.0002
906 PRODUCT DOSE OMISSION ISSUE 49 0.0002
907 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
908 MENTAL IMPAIRMENT 4 0.0002
909 UNDERDOSE 12 0.0002
910 INJECTION SITE HAEMORRHAGE 13 0.0002
911 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
912 WEIGHT INCREASED 36 0.0002
913 NERVOUS SYSTEM DISORDER 5 0.0002
914 DEATH 138 0.0002
915 INTESTINAL OBSTRUCTION 6 0.0002
916 INFLUENZA LIKE ILLNESS 13 0.0002
917 CARDIOVASCULAR DISORDER 4 0.0002
918 CONVULSION 9 0.0002
919 COLITIS ULCERATIVE 7 0.0002
920 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
921 THERAPY CESSATION 8 0.0002
922 NEUTROPENIA 21 0.0002
923 LACTIC ACIDOSIS 5 0.0002
924 SURGERY 9 0.0002
925 INFECTION 22 0.0002
926 VIRAL INFECTION 5 0.0002
927 PAIN OF SKIN 4 0.0001
928 DRUG EFFECT DECREASED 8 0.0001
929 EXTRA DOSE ADMINISTERED 6 0.0001
930 DISEASE RECURRENCE 7 0.0001
931 PNEUMONITIS 4 0.0001
932 MIGRAINE 14 0.0001
933 PSORIASIS 19 0.0001
934 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
935 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
936 INTENTIONAL PRODUCT MISUSE 12 0.0001
937 COVID-19 24 0.0001
938 PROSTATE CANCER 11 0.0001
939 RHEUMATOID ARTHRITIS 15 0.0001
940 SKIN IRRITATION 6 0.0001
941 BONE DENSITY DECREASED 4 0.0001
942 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
943 DRUG-INDUCED LIVER INJURY 4 0.0001
944 RENAL CANCER 6 0.0001
945 DEVICE BREAKAGE 5 0.0001
946 NEUTROPHIL COUNT DECREASED 5 0.0001
947 DEVICE ISSUE 11 0.0001
948 OSTEONECROSIS 4 0.0001
949 OVERDOSE 26 0.0001
950 RHABDOMYOLYSIS 5 0.0001
951 GAIT INABILITY 4 0.0001
952 ROAD TRAFFIC ACCIDENT 5 0.0001
953 UNEVALUABLE EVENT 9 0.0001
954 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
955 HEPATIC ENZYME INCREASED 8 0.0001
956 HOSPITALISATION 18 0.0001
957 IRRITABILITY 7 0.0001
958 DELIRIUM 4 0.0001
959 DRUG DOSE OMISSION 19 0.0001
960 MENTAL DISORDER 5 0.0001
961 INJECTION SITE BRUISING 9 0.0001
962 DRY SKIN 15 0.0001
963 THERAPY INTERRUPTED 8 0.0001
964 SKIN BURNING SENSATION 8 0.0001
965 ADVERSE EVENT 10 0.0001
966 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
967 ILLNESS 11 0.0001
968 DRUG WITHDRAWAL SYNDROME 9 0.0001
969 PLASMA CELL MYELOMA 4 0.0001
970 PSORIATIC ARTHROPATHY 4 0.0001
971 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
972 FLUSHING 10 0.0001
973 SKIN EXFOLIATION 8 0.0001
974 DEVICE DISLOCATION 4 0.0001
975 EMOTIONAL DISTRESS 11 0.0001
976 BREAST CANCER 8 0.0001
977 MULTIPLE SCLEROSIS 4 0.0001
978 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
979 ADVERSE DRUG REACTION 7 0.0001
980 SUICIDAL IDEATION 7 0.0001
981 DEVICE DIFFICULT TO USE 5 0.0001
982 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
983 INJECTION SITE ERYTHEMA 9 0.0001
984 BLADDER CANCER 4 0.0001
985 INJECTION SITE PRURITUS 4 0.0001
986 DEVICE MALFUNCTION 4 0.0001